Michael Goris
Overview
Explore the profile of Michael Goris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Renier C, Yao C, Goris M, Ghosh M, Katznelson L, Nowles K, et al.
Ann Surg Oncol
. 2009 Feb;
16(4):962-8.
PMID: 19184238
Background: The sodium iodide symporter (NIS) mediates iodide transport into cells and has been identified in approximately 70% of breast cancers. Functional NIS expression raises the possibility of using (131)I...
2.
Ghosh M, Gambhir S, De A, Nowels K, Goris M, Wapnir I
Mol Imaging
. 2006 Sep;
5(2):76-84.
PMID: 16954021
Optical imaging has made it possible to monitor response to anticancer therapies in tumor xenografts. The concept of treating breast cancers with (131)I is predicated on the expression of the...
3.
Horning S, Younes A, Jain V, Kroll S, Lucas J, Podoloff D, et al.
J Clin Oncol
. 2004 Dec;
23(4):712-9.
PMID: 15613695
Purpose: To determine overall response (OR) and complete response (CR) rates, response duration, progression-free (PFS) and overall survival and safety with the tositumomab and iodine-131 tositumomab ((131)I tositumomab) therapeutic regimen...
4.
Davis T, Kaminski M, Leonard J, Hsu F, Wilkinson M, Zelenetz A, et al.
Clin Cancer Res
. 2004 Dec;
10(23):7792-8.
PMID: 15585610
Purpose: A multicenter, randomized study was undertaken to estimate the single agent activity of Tositumomab and to determine the contribution of radioisotope-labeling with (131)I to activity and toxicity by comparing...
5.
Franc B, Yoshida E, Herfkens R, Goris M
Clin Nucl Med
. 2004 Oct;
29(11):741-2.
PMID: 15483497
No abstract available.
6.
Fisher D, Rajon D, Breitz H, Goris M, Bolch W, Knox S
Cancer Biother Radiopharm
. 2004 Aug;
19(3):293-307.
PMID: 15285876
Background: This paper provides a new model for calculating radiation-absorbed doses to the full thickness of the small and large intestinal walls, and to the mucosal layers. The model was...
7.
Wapnir I, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, et al.
Clin Cancer Res
. 2004 Jul;
10(13):4294-302.
PMID: 15240514
Purpose: The Na(+)/I(-) symporter (NIS) is a key plasma membrane protein that mediates active iodide (I(-)) transport in the thyroid, lactating breast, and other tissues. Functional NIS expression in thyroid...
8.
Franc B, Goris M
Clin Nucl Med
. 2002 Sep;
27(10):698-700.
PMID: 12352109
Technetium-99m tetrofosmin has been used as a tumor-imaging agent in cases of lung cancer. The authors present a case showing a lung tumor that concentrated Tl-201 distinctly more than Tc-99m...